Stanford University
Showing 26,341-26,350 of 36,196 Results
-
Sonia Rios-Ventura
Family Health Navigator, Medicine - Med/Oncology
BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.
She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing. -
Aditi Risbud Bartl, Ph.D.
Director, IT Strategic Communications, CIO Office, UIT
Current Role at StanfordDirector, IT Strategic Communications
University IT -
Dan Riskin
Clinical Professor (Affiliated), Surgery - General Surgery
Staff, Surgery - General SurgeryBioDr. Riskin is a Clinical Professor of Surgery at Stanford University and a physician–entrepreneur focused on the application of artificial intelligence in healthcare. His work spans clinical practice, company building, and public policy, with a focus on using clinical data to improve care.
He has founded and led multiple healthcare technology companies applying artificial intelligence to clinical data, with products used by leading health systems, pharmaceutical companies, and insurers and influencing the care of millions of patients. He is the CEO of Verantos, a healthcare AI company focused on improving the reliability of real-world clinical data used in research and care.
Dr. Riskin has contributed to health policy in the United States and internationally, including Congressional testimony related to the 21st Century Cures Act and service on the U.S. Health Information Technology Advisory Committee (HITAC). His work has been featured in The Wall Street Journal and Forbes.
Dr. Riskin received his MD from Boston University, completed residency in surgery at UCLA, and fellowship training in critical care and acute care surgery at Stanford University. He is board-certified in surgery, critical care, palliative care, and clinical informatics. He also holds an MBA from the Massachusetts Institute of Technology and was a Stanford Biodesign Innovation Fellow.
